How long does it take for estramustine (Adelox) to take effect?

Estramustine is an oral anti-tumor drug with dual effects of anti-androgen and chemotherapy. It is mainly used for the treatment of prostate cancer. Its mechanism includes inhibiting cell division by interfering with the microtubule function of tumor cells, while exerting estrogen-like effects to inhibit androgen-driven tumor growth. Since the mechanism of action involves cell cycle intervention, its efficacy often requires a certain amount of time to accumulate before it appears.

Clinical observation shows that after taking estramustine, some patients may experience a decrease in serum prostate-specific antigen (PSA) levels or a slight improvement in symptoms within 2–4 weeks. However, changes at this stage are usually slow and do not yet fully reflect a significant reduction in tumor burden. The initial efficacy is greatly affected by individual differences, tumor stage and basic treatment plan.

Usually after 8–12 weeks of continuous medication, the patient's efficacy evaluation will be more reliable, including PSA significant decrease, bone metastasis pain relief, imaging examination tumor volume stabilization or shrinkage, etc. At this stage, drug efficacy can be evaluated based on clinical response, and whether to optimize the regimen in combination with other endocrine treatments or chemotherapy drugs can be considered.

While taking estramustine, you should regularly monitorPSA levels, liver function and hematological indicators, and pay attention to drug tolerance and side effects. If no obvious effect is seen after continuous use for more than 3 months, the doctor may consider adjusting the dose or combining it with other treatment options. Through scientific follow-up and efficacy evaluation, it can be ensured that patients receive the best therapeutic effect while taking medication safely.

Reference materials:https://www.drugs.com/